Savara Inc Shareholders' Equity
Savara Inc (SVRA) had Shareholders' Equity of $143.66 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $143.66M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $176.04M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $203.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $94.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $143.66M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $176.04M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $203.13M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $94.39M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $120.48M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $147.85M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $171.45M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $199.35M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $101.73M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $121.86M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $140.37M 10-K · filed 2026-03-13 | |
| 2023-09-30 | $146.54M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $87.72M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $98.25M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $107.78M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $116.51M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $127.04M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $136.47M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $144.50M 10-K · filed 2024-03-07 | |
| 2021-09-30 | $155.23M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $165.38M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $175.12M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $64.38M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $76.63M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $83.80M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $87.32M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $101.70M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $106.80M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $112.80M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $101.80M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $108.22M 10-K · filed 2021-03-10 | |
| 2018-09-30 | $117.85M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $82.71M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $93.70M 10-Q · filed 2019-11-07 | $93.70M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $119.31M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $74.64M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $79.77M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.35M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$35.88M 10-K · filed 2019-03-13 | $9.76M 10-K · filed 2017-03-06 |
| 2016-09-30 | $13.19M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $16.43M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $20.68M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | -$27.33M 10-K · filed 2018-03-14 | $23.89M 10-K · filed 2016-03-14 |
| 2015-09-30 | $33.54M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $42.53M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $50.11M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$18.30M 10-K · filed 2018-03-14 | $58.66M 10-K · filed 2015-03-24 |
| 2014-09-30 | $45.25M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $50.22M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $52.79M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $47.81M 10-K · filed 2017-03-06 | $47.81M 10-K · filed 2014-03-26 |
| 2013-09-30 | $53.06M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $57.90M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $36.55M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $41.79M 10-K · filed 2015-03-24 | $41.79M 10-K · filed 2013-03-19 |
| 2012-09-30 | $46.29M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $49.08M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $52.96M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $56.78M 10-K · filed 2014-03-26 | |
| 2011-09-30 | $43.15M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $46.40M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $26.69M 10-K · filed 2014-03-26 | |
| 2009-12-31 | $6.67M 10-K · filed 2014-03-26 | |
| 2008-12-31 | $6.00M 10-K · filed 2014-03-26 | |
| 2007-12-31 | $31.03M 10-K · filed 2014-03-26 | |
| 2006-12-31 | $19.96M 10-K · filed 2014-03-26 | |
| 2005-12-31 | -$7.83M 10-K · filed 2014-03-26 | |
| 2004-12-31 | $12.39M 10-K · filed 2014-03-26 | |
| 2003-12-31 | $4.12M 10-K · filed 2014-03-26 | |
| 2002-12-31 | -$852.73K 10-K · filed 2014-03-26 | |
| 2001-12-31 | -$638.49K 10-K · filed 2014-03-26 | |
| 2000-12-31 | $14.61M 10-K · filed 2014-03-26 | |
| 1999-12-31 | -$1.23M 10-K · filed 2014-03-26 | |
| 1998-12-31 | -$525.26K 10-K · filed 2014-03-26 | |
| 1997-12-31 | $382.21K 10-K · filed 2014-03-26 | |
| 1996-12-31 | -$272.62K 10-K · filed 2014-03-26 | |
| 1996-06-11 | $0.00 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |